基于肠-肝-脑轴理论论治儿童抽动障碍的探讨

doi:10.20274/j.cnki.issn.1674-3865.2026.01.007

Abstract

Abstract:

Tic disorder is a chronic neuropsychiatric disorder predominantly affecting children and adolescents. In traditional Chinese medicine, its pathogenesis is primarily located in the liver, spleen, and brain, with the core mechanism being "disharmony of brain marrow and spiritual mechanism, and dysfunction of liver-spleen conveyance and drainage." Based on the "gut-liver-brain axis" theory, "dysfunction of liver-spleen conveyance and drainage" corresponds to intestinal microbiota dysbiosis, intestinal barrier damage, and hepatic metabolic dysfunction in modern medical concepts, which subsequently influence neuroimmune responses in the brain, leading to "disharmony of brain marrow and spiritual mechanism" Modulating brain function through intervening the intestinal microbiota, reducing hepatic burden, and downregulating inflammatory factors offers new therapeutic targets for the treatment of tic disorder. Traditional Chinese medicine approaches, including herbal formulas and acupuncture, can ameliorate tic symptoms by regulating the intestinal microecology and mitigating neuroinflammation. The "gut-liver-brain axis" theory provides a novel perspective and direction for the clinical management of tic disorder.

Key words: Tic disorder, Gut-liver-brain axis, Intestinal microbiota, Child

CLC Number:

R749.94

Ying LIU, Yuhang SUI, Di ZHANG. Exploration on the treatment for tic disorder in children based on the gut-liver-brain axis theory[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 35-39.

References 45

[1]	徐欣梅.基于脑肠轴理论从肝脾论治儿童抽动障碍的探讨[J].中国中西医结合儿科学,2023,15(5):384-388.
[2]	Trapecar M, Wogram E, Svoboda D, et al. Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases[J]. Sci Adv, 2021, 7(5): eabd1707.
[3]	陈蛟,张映林,刘作金.肝肠轴相关机制研究进展[J].现代医药卫生,2014,30(22):3405-3408.
[4]	Smith ML, Wade JB, Wolstenholme J, et al. Gut microbiome-brain-cirrhosis axis[J]. Hepatology, 2024, 80(2): 465-485.
[5]	D’Mello C, Swain MG. Liver-brain inflammation axis[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 301(5): G749-761.
[6]	Goehler LE, Gaykema RP, Hansen MK, et al. Vagal immune-to-brain communication: a visceral chemosensory pathway[J]. Auton Neurosci, 2000, 85(1-3): 49-59.
[7]	Harrison NA, Brydon L, Walker C, et al. Neural origins of human sickness in interoceptive responses to inflammation[J]. Biol Psychiatry, 2009, 66(5): 415-422.
[8]	Yasuda K, Churchill L, Yasuda T, et al. Unilateral cortical application of interleukin-1β (IL1β) induces asymmetry in fos, IL1β and nerve growth factor immunoreactivity: implications for sleep regulation[J]. Brain Res, 2007, 1131: 44-59.
[9]	D'Mello C, Swain MG. Immune-to-brain communication pathways in inflammation-associated sickness and depression[J]. Curr Top Behav Neurosci, 2017, 31: 73-94.
[10]	Moon J, Yoon CH, Choi SH, et al. Can gut microbiota affect dry eye syndrome[J]? Int J Mol Sci, 2020, 21(22): 8443.
[11]	Walrath T, Dyamenahalli KU, Hulsebus HJ, et al. Age-related changes in intestinal immunity and the microbiome[J]. J Leukoc Biol, 2021, 109(6): 1045-1061.
[12]	Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration[J]. J Physiol, 2017, 595(2): 489-503.
[13]	Bajaj JS. Alcohol, liver disease and the gut microbiota[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(4): 235-246.
[14]	Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy[J]. J Hepatol, 2020, 72(3): 558-577.
[15]	Wang Y, Kasper LH. The role of microbiome in central nervous system disorders[J]. Brain Behav Immun, 2014, 38: 1-12.
[16]	Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells—gatekeepers of hepatic immunity[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(9): 555-567.
[17]	Baizabal-Carvallo JF, Alonso-Juarez M. The link between gut dysbiosis and neuroinflammation in Parkinson's disease[J]. Neuroscience, 2020, 432: 160-173.
[18]	隆红艳,张骠.从“脑髓神机失调”角度认识小儿多发性抽动症的关键病机[J].辽宁中医杂志,2012,39(1):73-75.
[19]	程申,陈雅琴,王庆,等.王晓鸣教授运用调和肝脾法治疗儿童抽动障碍经验探讨[J].浙江中医药大学学报,2024,48(6):669-673.
[20]	赵赛,陈自佳.从“脑-肠轴”探讨肠道脂代谢异常在儿童抽动障碍中的作用机制[J/OL].中医学报,1-9[2026-01-03]..
[21]	Augustine F, Singer HS. Merging the pathophysiology and pharmacotherapy of tics[J]. Tremor Other Hyperkinet Mov (N Y), 2019, 8: 595.
[22]	Egolf A, Coffey BJ. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome[J]. Drugs Today (Barc), 2014, 50(2): 159-179.
[23]	任思洋. 静心止动方治疗中重度TD及对神经递质影响的研究[D]. 北京: 北京中医药大学, 2014: 1-73.
[24]	高汉媛, 王维红, 李小芹, 等. 菖蒲郁金汤对多发性抽动症模型大鼠单胺类神经递质的影响[J]. 中药药理与临床, 2017, 33(3): 135-138.
[25]	于文静, 白雪, 张雯, 等. 健脾止动汤对多发性抽动症患儿神经递质的影响[J]. 中华中医药杂志,2015, 30(5): 1757-1761.
[26]	康碧,陈宜.健脾止动汤联合耳穴贴压对儿童多发性抽动症的下丘脑-垂体-肾上腺轴激素、神经递质的影响[J].世界中医药,2019,14(6):1524-1527.
[27]	李旭蕊,李剑,李岩鹏,等.卡巴拉汀对阿尔茨海默病模型小鼠肠道菌群及认知功能的影响[J].现代生物医学进展,2020,20(20):3827-3831.
[28]	范菲,韩斐,汪琼.抽动障碍儿童血清TNF-α和IL-6的表达[J].江苏医药,2017,43(14):1005-1007.
[29]	刘守娟,乐原.血清总免疫球蛋白E、特异性免疫球蛋白E、维生素A、维生素D水平与儿童抽动障碍相关性分析[J].陕西医学杂志,2021,50(10):1257-1259.
[30]	王丹霞,孟珂,尚玉.肠道菌群情况与发声和多种运动联合抽动障碍患儿神经递质、神经功能及T细胞亚群的相关性分析[J].中国现代医学杂志,2024,34(16):56-61.
[31]	Konturek PC, Haziri D, Brzozowski T, et al. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases[J]. J Physiol Pharmacol, 2015, 66(4): 483-491.
[32]	García-Domínguez I, Veselá K, García-Revilla J, et al. Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson's disease[J]. Front Cell Neurosci, 2018, 12: 398.
[33]	Luczynski P, McVey Neufeld KA, Oriach CS, et al. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior[J]. Int J Neuropsychopharmacol, 2016, 19(8): pyw020.
[34]	范祎铭,鲍超,李建兵.基于脑-肠轴理论探讨针灸治疗抽动障碍作用机制[J].辽宁中医药大学学报,2025,27(4):134-139.
[35]	Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285): 59-65.
[36]	Wei C, Jiang W, Wang R, et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown[J]. Nature, 2024, 629(8013): 893-900.
[37]	张蔷,刘拓,王俊宏,等.菖菊止动方对抽动障碍患儿肠道菌群的影响[J].中国实验方剂学杂志,2024,30(23):104-110.
[38]	司原成, 苗维纳, 何嘉悦, 等. 基于“脑-肠-菌” 轴探讨健脾益气针法对肥胖鼠肠道菌群及TLR4的调控机制[J]. 中华中医药杂志, 2017, 32(10): 4457-4460.
[39]	常虹,唐烨霞,王紫玄,等.针刺联合小儿推拿对抽动障碍患儿肠道菌群的影响[J].中国针灸,2023,43(5):509-516.
[40]	罗文珍, 尚菁, 史正刚, 等. 菖蒲郁金汤对抽动-秽语综合征模型大鼠小胶质细胞的异常活化和神经炎症的影响[J]. 中医儿科杂志, 2023, 19(6): 1-9.
[41]	周红亮,陈洁,章建英,等.儿童抽动障碍与肠道菌群及炎症反应、免疫指标相关性研究[J].安徽医药,2024,28(6):1208-1211.
[42]	赵梦洁. 加味泻黄散经TLR4/NF-κB通路调控小胶质细胞极化治疗抽动障碍的机制研究[D]. 成都: 成都中医药大学, 2023.
[43]	张川,王伯韬,于雷雷,等.透明质酸调节肠道微生物和代谢物缓解炎症:一项分子量依赖性研究（英文）[J].Science Bulletin,2024,69(17):2683-2687.
[44]	曹思慧,陈琳,何灏龙,等.基于1H-NMR和16S rDNA测序技术探讨针与灸不同刺激方法对大鼠结肠代谢物和肠道菌群的影响[J].中国病理生理杂志,2023,39(9):1620-1633.
[45]	Wang H, Chen D, Li H, et al. Bifidobacterium regulates premature infant gut metabolites, reducing serum inflammatory factors: a randomised controlled trial[J]. Pediatr Res, 2024, 97(3): 1171-1182.

Exploration on the treatment for tic disorder in children based on the gut-liver-brain axis theory

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 45

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhonghe ZENG, Longming LEI, Jun ZHAO, Qiongxiao WANG, Lin FU, Mengyun WU, Danlu SU, Guanghui CHEN. A network Meta-analysis of the clinical efficacy of guideline-recommended external treatment of traditional Chinese medicine for anorexia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 23-30.
[2]	Fang CHENG, Hong XIANG. Treatment for pediatric upper airway cough syndrome based on the "Xuanfu and Qi-Fluid Theory" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 31-34.
[3]	Siang HAN, Xinye ZHANG, Yichen LIN, Chang CAI, Zhenqi WU. On the treatment for pediatric cough variant asthma from the theory of "liver ascending and lung descending" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 40-44.
[4]	Jingnan XUE, Qing YANG, Yan ZHANG, Liujin JIA. Professor Jia Liujin's experience in treating atopic dermatitis in children based on the theory of "spleen bitterness and dampness" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 45-49.
[5]	Shengjuan QIN, Heyin XIAO, Kai GUO, Ziyan ZHANG. Experience in treating mesenteric lymphadenitis in children from the perspective of throat [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 50-53.
[6]	Lipeng SHAO, Yan HU. Exploring the treatment for childhood tic disorders by the Huxiang Medical School based on data mining [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 54-59.
[7]	Muyuan WAN, Pengfei YI, Qingyi XU, Jinsong YAN, Tian ZHANG, Liqin LIU, Mengqi CHEN, Qingqing LI. Systematic analysis of pediatric Chinese patent medicines and simple preparations included in the 2025 edition of the Chinese Pharmacopoeia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 60-66.
[8]	Wanying CHANG, Youqi DONG. Case examples of Dong Youqi's application of Erchen decoction and its derivatives prescriptions in treating infantile phlegm-damp syndrome [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 67-70.
[9]	Sen KONG, Liang ZHANG, Nan LIAO, Guang TU. Application research on risk factor analysis of severe Mycoplasma pneumoniae pneumonia in children based on random forest model [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 71-76.
[10]	Yawen SONG, Bo CHEN. Research on the association between vitamin D and acute inflammation complicated by anemia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 77-81.
[11]	Ruiqi CAI, Oumei HAO, Xuefeng WANG, Kexin ZHANG. Clinical observation of Xiaoji Lipi powder and anorexia plaster combined with conventional treatment for children with anorexia(spleen dysfunction syndrome) [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 461-465.
[12]	Qing WANG, Yaqin CHEN, Danfei YIN, Suli WANG, Xiaoming WANG. Exploration of prescription patterns in Professor Wang Xiaoming's treatment for pediatric food accumulation and stagnation based on data mining [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 466-471.
[13]	Qimin TANG, Yishi TU. Observation on the curative effect of Jianpi Yiqi ointment in treating anorexia(spleen and stomach qi-deficiency syndrome) in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 472-476.
[14]	Xuefeng WANG, Qi WANG, Minghua BAI, Ji WANG, Hua XU, Lining WANG, Baoqing ZHANG, Zhenze CUI, Zhenqi WU, Xue ZHAO, Xiuying ZHANG, Xinyue KONG, Hao HE, Xinwei LIU. Study on the assessment of "the TCM Constitution Scale for Children Aged 1⁺ to 7 Years" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 477-487.
[15]	Yijue JING, Zhengyu YAO, Lü GAO. Research advances in the treatment of pediatric epilepsy with Pingxian granules [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(6): 488-492.